JAMA Oncology

Racial disparity in breast cancer mortality linked to genesUnderstanding genetic variations and tumor differences in black women with breast cancer could lead to personalized diagnosis and treatment.
Sharp price increases for cancer drugs
Sharp price increases for cancer drugsA majority of oncology drugs—particularly older cancer drugs—had price hikes in 2015, according to a study. Plus, Ariad Pharmaceuticals raised the price of its chronic myeloid leukemia (CML) drug ponatinib (Iclusig) for the fourth time this year to around $199,000 a year, according to The Street.